Viridian Therapeutics
VRDN
VRDN
225 hedge funds and large institutions have $2.21B invested in Viridian Therapeutics in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 80 increasing their positions, 67 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
34% less capital invested
Capital invested by funds: $3.36B → $2.21B (-$1.14B)
41% less call options, than puts
Call options by funds: $6.26M | Put options by funds: $10.7M
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
Holders
225
Holding in Top 10
6
Calls
$6.26M
Puts
$10.7M
Top Buyers
| 1 | +$70.3M | |
| 2 | +$53.8M | |
| 3 | +$50.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$48.7M |
| 5 |
BlackRock
New York
|
+$41.6M |
Top Sellers
| 1 | -$55.6M | |
| 2 | -$33.6M | |
| 3 | -$33.4M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$32.9M |
| 5 |
EP
Eversept Partners
New York
|
-$31.7M |
